Terms: = Prostate cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Diagnosis
104 results:
1. Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer.
Huang B; Yang K
Genes Genomics; 2023 Sep; 45(9):1197-1209. PubMed ID: 37311953
[TBL] [Abstract] [Full Text] [Related]
2. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
[TBL] [Abstract] [Full Text] [Related]
3. Nanoarchitectonics-Assisted Simultaneous Fluorescence Detection of Urinary Dual miRNAs for Noninvasive diagnosis of prostate cancer.
Jiang P; Bai Y; Yan L; Feng P; Huang K; Chen J; Chen P
Anal Chem; 2023 May; 95(19):7676-7684. PubMed ID: 37129316
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.
Jang A; Lanka SM; Huang M; Casado CV; Caputo SA; Sweeney PL; Gupta K; Pocha O; Habibian N; Hawkins ME; Lieberman AD; Schwartz J; Jaeger EB; Miller PJ; Layton JL; Barata PC; Lewis BE; Ledet EM; Sartor O
Prostate; 2023 Aug; 83(11):1028-1034. PubMed ID: 37113064
[TBL] [Abstract] [Full Text] [Related]
5. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of prostate Biopsy Outcome.
Juracek J; Madrzyk M; Trachtova K; Ruckova M; Bohosova J; Barth DA; Pichler M; Stanik M; Slaby O
Cancer Genomics Proteomics; 2023; 20(3):308-316. PubMed ID: 37093688
[TBL] [Abstract] [Full Text] [Related]
6. Silencing LINC00491 inhibits prostate cancer development through the miR-384/TRIM44 axis.
Zhou S; Wu C; Tang Q; Zhou X; He B; Chang P; He X
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23370. PubMed ID: 37070216
[TBL] [Abstract] [Full Text] [Related]
7. P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer.
Röbeck P; Xu L; Ahmed D; Dragomir A; Dahlman P; Häggman M; Ladjevardi S
Prostate; 2023 Jun; 83(9):831-839. PubMed ID: 36938873
[TBL] [Abstract] [Full Text] [Related]
8. [
Maurin M; Wyczółkowska M; Sawicka A; Sikora AE; Karczmarczyk U; Janota B; Radzik M; Kłudkiewicz D; Pijarowska-Kruszyna J; Jaroń A; Wojdowska W; Garnuszek P
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364046
[TBL] [Abstract] [Full Text] [Related]
9. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
10.
Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
[TBL] [Abstract] [Full Text] [Related]
11. Single-atom Pt-anchored Zn
Li B; Guo L; Chen M; Guo Y; Ge L; Kwok HF
Biosens Bioelectron; 2022 Apr; 202():114006. PubMed ID: 35091371
[TBL] [Abstract] [Full Text] [Related]
12. kit-based preparation of [
Hong H; Wang G; Ploessl K; Zha Z; Zang J; Zhu Z; Zhu L; Kung HF
Nucl Med Biol; 2022; 106-107():1-9. PubMed ID: 34952347
[TBL] [Abstract] [Full Text] [Related]
13. Detection of COX-2 in liquid biopsy of patients with prostate cancer.
Pereira VS; Alves BDCA; Waisberg J; Fonseca F; Gehrke F
J Clin Pathol; 2023 Mar; 76(3):189-193. PubMed ID: 34782424
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of a rapid one-step PSA test for primary prostate cancer screening.
Ashida S; Yamasaki I; Kawada C; Fukuhara H; Fukata S; Tamura K; Karashima T; Inoue K; Shuin T
BMC Urol; 2021 Sep; 21(1):135. PubMed ID: 34579701
[TBL] [Abstract] [Full Text] [Related]
15. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract] [Full Text] [Related]
16. [Pathological features of primary extragonadal germ cell tumor of the prostate with small round blue cell morphology].
Gan HL; Wang QF
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):108-113. PubMed ID: 33535304
[No Abstract] [Full Text] [Related]
17. Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.
Xu Y; Li Z; Shi J; Fu Y; Zhu L; Fan X; Foo WC
Virchows Arch; 2021 Apr; 478(4):619-626. PubMed ID: 32820389
[TBL] [Abstract] [Full Text] [Related]
18. A Rare Case of Inflammatory Myofibroblastic Tumor of the prostate and Review of the Literature.
Kim MS; Lim SC
In Vivo; 2020; 34(4):2043-2048. PubMed ID: 32606180
[TBL] [Abstract] [Full Text] [Related]
19. Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer.
Jin D; Zhang R; Chen H; Li C
Aging (Albany NY); 2020 Jun; 12(11):10844-10862. PubMed ID: 32534450
[TBL] [Abstract] [Full Text] [Related]
20. Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis.
Luo ZF; Peng Y; Liu FH; Ma JS; Hu G; Lai SL; Lin H; Chen JJ; Zou GM; Yan Q; Sui WG
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4697-4709. PubMed ID: 32432733
[TBL] [Abstract] [Full Text] [Related]
[Next]
